News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

 

ART Announces Acquisition of an Exclusive License to an Important Patent Portfolio in the Medical Sector (Canada NewsWire)...which will use time domain technology to detect and diagnose breast tumors.......~~~Acquiring the exclusive worldwide license rights to such an extensive patent portfolio will allow ART to complement its own intellectual property with respect to time domain imaging and will also assist ART to develop its SoftScan(TM) technology for other applications, including the detection and imaging of brain tumor, head injuries (hematoma) and strokes~~~ said Paul Bisson,...- Apr 11 6:00 AM ET


IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/cnw/010411/a_art_patent_medical.html


(Everything below this line is from VirtualTrials.com!)

Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740